Thailand is set to become the most pro-cannabis Country in Asia

In Thailand, the seeds of a cannabis awakening are beginning to grow as restrictions on the plant lessen.

While the country has been one of America’s biggest allies when it comes to the War on Drugs, the conservative military-run nation is beginning to peel back the harsh anti-pot laws and opening the doors to medical research.

Thailand has a long history with the plant, where the words “bong” and “ganja” originated, which is also very much intertwined with our own American history with the plant. In December, it became the first country in Asia to legalize medical marijuana.

Citing the success of the western push to legalize cannabis both monetary and medically, Thailand is currently in a race with Malaysia to become the center of marijuana in Asia.

What is Thailand Doing?

While steps are being made toward legalization, they are baby steps.

Almost every country in Asia has been firmly against cannabis for decades, with many countries following the lead set by America for the War on Drugs. Being caught with the drug can mean a hefty fine or serious jail time depending on the amount.

Thailand has walked toe to toe with America in the War on Drugs, with the country having the largest prison system in the region, and 70 percent of the inmates jailed on drug crimes. While methamphetamines are seen as the biggest problem in the country, ganja smokers are considered to be cut from the same cloth.

The official word for marijuana in the region is “ganja,” where it is a class 5 drug, which is the most severe ranking in the country.

In Thailand, not only are police allowed to stop and search anyone, but they can also “force people to pee in cups, right on the street, and test their urine for drugs,” according to Public Radio International.

Thai traffic policeman in working action

However, times are changing, and now cannabis is considered to be “a top priority” by the Thai government, which is seeking to create “world-class cannabis” for use. 

Last December, the country quietly allowed medical marijuana research to begin in the country. The vote was unanimous, showing a change in temperament in the country and the region.

Policy makers in the country are saying that a global shift in legalization has lead to a large destigmatization in the country, while others point to America’s weakening influence on the country.

Another big push for the plant is coming from the big pay day expected.

“It will wake up the agricultural industry in Thailand,” Chokwan “Kitty” Chorpaka, a Thai activist, tells PRI. “We’re that country that loves to promote cash crops: rice and rubber and palm oil. Cannabis is just another cash crop that they want to bring in and stimulate the economy.”

The plant grows well in the nation, which is well suited for year round growing and vast amounts of land.

Currently, the country has a medical marijuana system that will treat cancer, multiple sclerosis, chronic pain, epilepsy and more in the beginning. Research centers looking into more possible benefits are also being set up in the country.

Scientists in the country have already come up with a series of products aimed at helping reduce pain in those suffering, including THC-infused wafers, massage oils, a nasal spray and a powder that mixes up some of Thailand’s most notable spices.

The powder prototype would be mixed with coconut oil with sandalwood, ginger and three types of pepper to form a coconut flavored drink.

Will Recreational Cannabis Come to Thailand?

In July, an even bigger push was made with the introduction of a bill that would allow citizens to grow their own plants and begin setting up a recreational market. While it will most likely be a few more years before a full recreational system will be put into place, the enthusiasm behind the plant is growing. 

At the time, Thai Prime Minister Prayuth Chan-ocha set out the ground work to begin looking more into the issue, which has become a top priority for the Bhumjaithai party, one of the biggest parties in the country’s 19-party coalition.

Thai Prime Minister Prayuth Chan-ocha

Thai Prime Minister Prayuth Chan-ocha

“The study and technological development of marijuana, hemp, and other medicinal herbs should be sped up for the medical industry to create economic opportunity and income for the people,” the policy document released by the government said.

While there is excitement in the government, many are reluctant until they see the science, which may take a year or two to fully begin in Thailand.

At Rangsit University, where the first cannabis research programs are being developed, the main focus is currently on medical purposes.

Supachai Kunaratnpruk, a former Thailand’s health minister who is now leading Rangsit University’s research efforts, told PRI that “We can’t let it fall into one [set of] hands, one big company. Our responsibility is to develop special Thai strains of world-class cannabis used in medicine. We want to cooperate with farmer co-ops. They grow it, we provide knowledge and it’s all sold to the medical profession. That’s the model.” 

A vote is expected on a bill by the Bhumjaithai party that would open the door for home-grown legalization in the coming months, however, it is doubtful that it will come to fruition this early.

What About The Rest of Asia?

Most of Asia has a relatively harsh stance against the drug, with some countries having death penalties if caught.

One of those countries, Malaysia, downgraded the punishment for being caught with the drug last year and have quietly moved toward enacting their own cannabis programs in the country.

China, South Korea and the Philippines have also made baby steps toward a more marijuana friendly world recently, with the countries beginning to look into more research and medical programs.

While the driving factor for many of the countries may well be profit, the lesser restrictions and punishments for marijuana are a sign of the times.

How CBD helps with postpartum depression

Motherhood comes with tons of questions and a myriad of complications. One such major issue is postpartum depression. A study by the US National Library of Medicine reports that approximately 15% of mothers encounter postpartum depression. The actual number might be higher, as many cases go unaccounted. Many new parents are turning to CBD for help instead of relying entirely on prescriptions and psychotherapy. Is it fruitful? Let us find out.

Postpartum Depression: How is it Different from Baby Blues?

Postpartum Depression (PPD) is a severe long-term postnatal complication where the mother is unable to bond with her child, is guilt-ridden about accidentally hurting the child or not being able to be a good mother, and has suicidal thoughts. A much rare form of postpartum depression involves hallucinations, delusions, and other psychotic symptoms. It is postpartum psychosis.

The National Institute of Mental Health reports that there is no particular cause of postpartum depression. It is a combination of both physical and emotional factors. Lack of sleep, hormonal imbalances, chronic pain, and other physical changes along with the sudden lifestyle shift and surge in responsibilities severely affects a new mother’s mental health. While it resembles baby blues in many ways, do not confuse the symptoms of postpartum depression with the other one and leave it untreated. Baby blues go away after the initial few weeks but, PPD lingers longer and requires a psychiatrist’s help.

Symptoms of Baby Blues and Postpartum Depression:

The characteristics of baby blues are a numb sensation, uncontrolled crying, fatigue, impatience, insomnia, headaches, drastic mood swings, anger issues, sadness, irritability, panic attacks, etc. In postpartum depression, these symptoms appear in an aggravated state. There’s also loneliness, loss of appetite, lack of energy, cognitive disabilities, loss of interest in hobbies or any other activities, development of pessimistic attitude in all aspects of life, chronic pain, blurred vision, and even suicidal attempts. 

What does Research say about CBD and Depression?

CBD or cannabidiol improves the functioning of the endocannabinoid system (ECS), a human system responsible for maintaining homeostasis and regulating emotions in humans. A 2014 review states that CBD can act as an effective antidepressant and anti-anxiety drug in animal models.

The authors of a 2018 review found that both long-term and short-term use of CBD products showed promising progress in anxiety and stress management. The compound works without directly stimulating the endocannabinoid receptors in the brain. So, chances of CBD addiction are quite low. It can even minimize cravings in people experiencing opioid use disorder.  

Treating Postpartum Depression: Can CBD Help?

With studies providing evidence of health benefits, today, CBD is becoming increasingly popular in the treatment of postpartum depression. As such, breastfeeding is one of the significant aspects of CBD’s effectiveness in treating PPD. Several studies show that breast milk naturally contains endocannabinoids. Intake of CBD in any form adds to cannabinoid content of breast milk. Mothers, who felt disconnected from their child as an outcome of PPD, claimed that CBD potentially flared up their confidence to breastfeed their children. 

Additionally, CBD can also

  1. a) Reduce Pangs of Anxiety in PPD

Women with postpartum depression often feel stressed and anxious and experience sudden pangs of a panic attack. While it is not unusual in women during the first few weeks after delivery, it becomes a matter of concern if it lasts longer and takes the form of postpartum anxiety disorder. Around 4 – 11% of women experience postpartum anxiety, however, so many more cases go unreported.

As children are receptive to their parent’s emotions, seeing an anxious or stressed out mother might develop anxiety in the child too. Accompanied by excessive crying and lack of sleep, anxiety may hamper the child’s overall growth.

CBD has shown promise in the treatment of anxiety-related symptoms. When you start moving very fast at the onset of a panic attack, a neurotransmitter called GABA serves as a brake pedal for the nervous system and helps you relax. CBD interacts with this neurotransmitter and enhances its binding capacity. So, you can buy weed online to treat anxiety symptoms during the postpartum period. 

  1. b) Help you get a Sound Sleep

A usual condition and symptom of postpartum depression is lack of sleep. The large scale neurological changes and hormonal imbalances occurring inside a woman’s body in the changing context of new motherhood cause postpartum insomnia.

Negative amounts of sleep may heighten the challenges of parenting, interrupt life, and impair the mother’s ability to care for the baby and herself. Celia Bahar, a therapist in Ithaca, New York, recalls insomnia worsening the symptoms of her postpartum depression such as numb detachment, hysterical tears, feelings of unworthiness and self-hatred following the birth of her first and second daughter. Only when she had started using homegrown marijuana, she found her insomnia vanishing.

Like Celia Bahar, many other moms worldwide have spoken about the significant improvements they witnessed in PPD with the administration of CBD, thanks to its relaxing and sedating effects. Studies show that doses larger than 200 mg help insomniacs fall asleep faster, remain asleep longer, and wake up with a refreshing feeling the next day. 

CBD v/s Prescribed Antidepressants for PPD

Talk about postpartum depression to doctors and most of them are likely to prescribe antidepressants like Lexapro, Prozac, or Zyban. While they make you active and may cure the depression with prolonged use, they herald negative effects like weight loss, increased lack of sleep, migraine, shaky hands, dizziness, and nausea. To avoid these drawbacks and deal with PPD more effectively, many mothers resort to CBD products from Sabaidee CBD company. Unlike anti-anxiety medicines, in no way does CBD impair her childcare capabilities, says Jo Highland, mother of two in Ohio and part of the growing community of CBD consumers.

How much CBD should you take?

The key to leveraging the therapeutic benefits of CBD is using it in moderation, especially during breastfeeding. For mothers who wish to start smoking medical marijuana or take CBD supplements, doctors recommend starting intake with small quantities, preferably 25 – 50 mg per day, at a consistent hour of the day. Gradually, you can increase the amount.

Like Dr. Kevin Gilliland, the executive director of Innovation 360, an outpatient treatment facility, most medical professionals suggest a multi-faceted approach in the treatment of postpartum depression. Since PPD demands quick relief, CBD fills in the drawback of slow responses from regular medication and counselling. With CBD, you need not fear about getting high as the psychoactive compound THC is absent in it. Consult your psychiatrist and invest in budget buds to remain happy and connect with your child during one of the most challenging periods in life.

2 cannabis stocks to watch heading into October

The marijuana stock market has shifted dramatically over the course of the past few years. In that time, we have seen the industry become more friendly to outside investors, allowing pot stocks to flourish, and new technology to become more available than ever. With so many different pot stocks to watch in the market, it can be a daunting task to pick just one. This choice, however, is made much easier by the amount of research that one is willing to put into finding the right pot stocks to watch.

With ample research, it seems that one can avoid large surprises when it comes to price action. One must also note that volatility in the marijuana stock market is somewhat unavoidable. Given that the industry itself is so new, it seems as though the price action we have seen has been quite up and down. This, however, is a positive for some investors as it allows for the potential of larger gains. One should also note that the potential for larger losses is there as well. All in all, these pot stocks to watch are making big moves for the near future.

A Vertical Pot Stock to Watch

1933 Industries Inc. (TGIFF Stock Report) (TGIF Stock Report) is one of the leading vertically integrated marijuana stocks to watch. The company currently has operations in both the U.S. and Canada. With their broad reach, they have been able to enter into branding, cannabis cultivation, extraction, processing and the manufacturing of assets. Some of their in house brands include AMA Flower and AMA Concentrates, CBD-infused Canna Hemp, Canna Hemp X and more. With these partners, they have been able to secure one of the top spots in the pot stock market. Vertical integration has also been named as one of the key factors to success in the pot stock market.

The company recently announced that they have entered into a licensing agreement for the launch of Blonde, a high end Californian cannabis brand currently working its way into the Nevada market. Under the one year agreement, their subsidiary Alternative Medicine Association, will receive exclusive rights to cultivate flower, manufacture pre-rolls and produce other products made under the Blonde brand name. For this reason, they remain a key pot stock to watch moving forward.

A Canadian Cannabis Stock

OrganiGram Holdings (OGI Stock Report) is one of the leading Canadian pot stocks and one of the largest growers of marijuana in the world. The company has seen some issues in the past few months as supply worries have plagued the Canadian pot market.

One of the ways in which this has been somewhat solved has been a large issuance of growth licenses in the country. The company is still working off of an operating loss, but it seems as though many in the cannabis market are due to the capital intensive process of opening a cannabis business. Regardless, their massive growth amount makes them one of the interesting pot stocks to watch throughout the near future.

Hemp experts criticize THC state testing protocols

In 2018, Colorado farmers had to destroy hundreds of acres of hemp because the plants exceeded a limit for the psychoactive compound responsible for the “high” in marijuana.

Colorado is among the states that require the top two inches of the plant be tested for THC, said Eric Steenstra, president of the advocacy group Vote Hemp.

Industry experts said the testing protocol doesn’t make sense because, in part, it isn’t representative of the THC content dispersed throughout the entire plant from which finished products are sourced.

“Whether or not a plant meets regulatory compliance literally matters what state you’re growing in,” said Chris Hudalla, Ph.D., founder and chief scientific officer of ProVerde Laboratories Inc., in Milford, Massachusetts, which provides analytical testing and consulting services in the marijuana and hemp industries.

Hudalla made those remarks during the Aug. 16 Hemp-CBD Supplement Congress in Denver hosted by the American Herbal Products Association (AHPA).

THC results, he explained, will depend on such variables as whether the top three or 12 inches of the plant are collected; and whether the top, middle and bottom of the plant are sampled and combined for testing.

Consider regulations in Vermont, where a spokesperson for the agency overseeing agriculture said no hemp had to be destroyed in 2018. The Vermont Agency of Agriculture requests THC testing for the top eight inches of a plant’s “side arm flower,” spokeswoman Stephanie Smith said.

Farmers in Vermont can salvage a crop if it exceeds a THC limit under certain conditions. “If the delta-9 THC concentration is greater than 0.3%, but a total theoretical THC concentration [is] 1% or less, the agency would allow the crop to transfer to a processor for removal of THC,” Smith said. “The compliant concentrate could be sold.”

Sunny Summers is cannabis policy coordinator for the Oregon Department of Agriculture. In an email, she said plant material that exceeds 0.3% delta-9 THC in preharvest testing must be destroyed.

In Oregon, the top eight inches of flowering tops are collected for testing, according to a document Summers forwarded. In 2018, less than 1% of preharvest tests failed, she said.

In a follow-up interview, Hudalla explained his critique of state procedures in which the top portion of the plant is tested for THC.

“We don’t use the top three inches of the plant to create products,” he said. “We use the whole plant to create products. So why are we taking the portion that has the highest amount of THC to evaluate if a plant is going to be within regulatory compliance?”

Brian Koontz, industrial hemp program manager with the Colorado Department of Agriculture, said 741 acres of hemp were destroyed in 2018 because they exceeded .39% THC.

“Our rule states that hemp greater than .3% and less than 1% can be destroyed or utilized on site in a manner approved of and verified by the Commissioner [of Agriculture],” Koontz explained via email.

But he added, “There has been no approved method to salvage hemp on site to date.”

Attorney Maureen West used to have Koontz’s job and worked at the Colorado Department of Agriculture for three years.

“I don’t think there’s any reason that farmers should be destroying crops,” West, now general counsel with Functional Remedies in Superior, Colorado, said at AHPA’s conference. “I think we need to find solutions. There are solutions.”

Asked to address criticism that Colorado officials should not be testing the top portion of the plant, Koontz cited rules defining industrial hemp as “a plant of the genus Cannabis and any part of the plant, whether growing or not, containing a delta-9 tetrahydrocannabinol (THC) concentration of no more than three-tenths of one percent (0.3%) on a dry weight basis.”

Hudalla described the 0.3% standard as “meaningless.”

“Whether or not your sample meets regulatory compliance has nothing to do with the amount of THC in your plant,” he said in the interview. “It has to do with how the state is going to collect the sample and test for it.

“It’s terribly frustrating,” the analytical chemist added. “I have farmers [who] are in states that have appropriate sampling plans, and they have no issues.”

Industry experts are hopeful USDA will promulgate sensible standards governing THC testing in its regulations for the production of hemp. USDA has drafted regulations that were sent to the White House’s Office of Management and Budget (OMB) for inter-agency review, a spokesperson for USDA said via email.

“It is USDA’s intention to have regulations in effect in time to accommodate the 2020 planting season,” the spokesperson said.

In an email, Steenstra of Vote Hemp said he has “advocated strongly” that USDA “use a composite plant approach, including parts of the entire plant for testing.”

During AHPA’s conference, an attorney based in Washington—Jessica Wasserman of Greenspoon Marder LLP—asked a USDA official about a national standard related to THC testing.

“Our goal is to provide a consistent, easy-to-follow regulatory framework around hemp production,” responded Bill Richmond, chief of USDA’s Hemp Program. “And I can’t speak to whether that means a hard prescriptive set of requirements for everybody at this stage, but our goal is to provide consistent standards that make sense for growers and for the industry, and don’t put farmers out of business. And that’s our intent.”

AC Braddock, chair of the National Cannabis Industry Association, said regulators don’t understand that they can mitigate THC content through extraction.

“There’s just so many things that are extremely detrimental to these businesses just because the regulators don’t understand what they’re dealing with, and they don’t look at other states as much as they should to see what this other state did,” said Braddock, CEO of Seattle-based Eden Labs, a manufacturer of extraction equipment, in an interview.

Eleanor Kuntz, Ph.D. is CEO of LeafWorks Inc., an herbal genetics company in Sebastopol, California. During the AHPA conference, she noted the same plants grown in different parts of the country “produce different chemicals,” and Kuntz explained factors such as temperature and water levels can change the plant’s chemistry.

“The chemistry is something that’s going to dictate whether your plants are legal or not, or compliant,” she said in a follow-up interview. “That’s a big deal.”

Kuntz described THC policies as “silly.” If THC is going to be regulated, she added, “we need to have a flexible way of regulating, and you need to allow farmers a way to remediate their crops.”

Hollis Glenn is director of the Division of Inspection and Consumer Services with the Colorado Department of Agriculture, and he is among those leading a groundbreaking hemp supply chain initiative known as CHAMP (Colorado Hemp Advancement & Management Plan).

Glenn said he couldn’t respond to criticism over Colorado’s THC testing procedures because it’s not his program. However, he suggested stakeholders in CHAMP are discussing such issues. In fact, stakeholders in the CHAMP initiative have broken out into eight working groups, including a testing group.

“This is a collaborative stakeholder process, so we want to hear from all those opinions,” Glenn said in an interview. “We want to engage in CSU [Colorado State University] and their outside experts to do their research to figure out … what is the standard across the country.”

Industry sources suggested farming is hard enough without unnecessary impediments from regulators.

“I know one farmer in Arizona who spent US$300,000 buying hemp young plants, and every one of them died,” said Josh Schneider, principal of Cultivaris North America LLC, a global horticultural company, during AHPA’s conference. “In my estimation, 50% of the farmers who plant hemp this year will lose their entire crop, and that’s probably a low number.”